Recent and current work have incorporated some details of the associated breast cancer pathology into risk models, but this effort has essentially been restricted to immunohistochemical data such as estrogen receptor (ER), progesterone receptor (PR), HER2 and cytokeratin (CK5/6, CK14) status [2-4]. The gene discussed is PGR; the disease is breast carcinoma.